TUDOR INVESTMENT CORP ET AL Alnylam Pharmaceuticals, Inc. Transaction History

TUDOR INVESTMENT CORP ET AL portfolio value:

$5.97M
portfolio value

TUDOR INVESTMENT CORP ET AL quarter portfolio value change:

+37.24%
quarter

Alnylam Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +1518.37% 28.01K shares 5.70M $200.16 29.85K
Q2 2022 share Increase 0.00% 1.84K shares 269K $145.85 1.84K
Q1 2022 share Decrease -100.00% -24.05K shares -4.08M $163.29 0
Q4 2021 share Decrease -14.85% -4.19K shares -1.25M $171.03 24.05K
Q3 2021 share Increase 0.00% 28.25K shares 5.33M $188.81 28.25K
Q2 2021 share Decrease -100.00% -19.02K shares -2.68M $169.52 0
Q1 2021 share Increase 0.00% 19.02K shares 2.68M $141.19 19.02K
Q2 2020 share Decrease -100.00% -3.66K shares -399K $148.11 0
Q1 2020 share Decrease -36.16% -2.07K shares -263K $108.85 3.66K
Q4 2019 share Increase 0.00% 5.74K shares 662K $115.17 5.74K
Q3 2019 share Decrease -100.00% -29.98K shares -2.17M $80.42 0
Q2 2019 share Increase 0.00% 29.98K shares 2.17M $72.56 29.98K